EREG | Epiregulin | Predicted membrane proteins
| | | | | Tissue enriched |
FAM178B | Family with sequence similarity 178, member B | | | | | | Group enriched |
H1FX | H1 histone family, member X | Plasma proteins
| | | | | Tissue enriched |
HIST1H3B | Histone cluster 1, H3b | Cancer-related genes
| | | | | Tissue enriched |
IL8 | Interleukin 8 | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
LY6G6F | Lymphocyte antigen 6 complex, locus G6F | Predicted membrane proteins
| | | | | Tissue enriched |
NRIP3 | Nuclear receptor interacting protein 3 | | | | | | Group enriched |
PF4 | Platelet factor 4 | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
PPAPDC1A | Phosphatidic acid phosphatase type 2 domain containing 1A | Enzymes Predicted membrane proteins
| | | | | Group enriched |
PPBP | Pro-platelet basic protein (chemokine (C-X-C motif) ligand 7) | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
SLFN14 | Schlafen family member 14 | | | | | | Tissue enriched |
CEACAM6 | Carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen) | Cancer-related genes CD markers Predicted membrane proteins
| | | | | Group enriched |
CLEC5A | C-type lectin domain family 5, member A | Predicted membrane proteins
| | | | | Group enriched |
DNAH10 | Dynein, axonemal, heavy chain 10 | | | | | | Group enriched |
FCN1 | Ficolin (collagen/fibrinogen domain containing) 1 | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
FUT4 | Fucosyltransferase 4 (alpha (1,3) fucosyltransferase, myeloid-specific) | Predicted membrane proteins
| | | | | Tissue enriched |
GPR97 | G protein-coupled receptor 97 | G-protein coupled receptors Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
HYAL3 | Hyaluronoglucosaminidase 3 | Enzymes Predicted secreted proteins
| | | | | Group enriched |
ITGAM | Integrin, alpha M (complement component 3 receptor 3 subunit) | Cancer-related genes CD markers Disease related genes Predicted membrane proteins
| | | | | Group enriched |
MMP25 | Matrix metallopeptidase 25 | Enzymes FDA approved drug targets Predicted secreted proteins
| | | | | Group enriched |
NTNG2 | Netrin G2 | Predicted secreted proteins
| | | | | Group enriched |
SELL | Selectin L | Cancer-related genes Candidate cardiovascular disease genes CD markers Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
SPNS3 | Spinster homolog 3 (Drosophila) | Predicted membrane proteins
| | | | | Tissue enriched |
TCTEX1D1 | Tctex1 domain containing 1 | | | | | | Group enriched |
TREM1 | Triggering receptor expressed on myeloid cells 1 | CD markers Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
AC104534.3 | Delta(3,5)-Delta(2,4)-dienoyl-CoA isomerase, mitochondrial | | | | | | Tissue enhanced |
ADAM8 | ADAM metallopeptidase domain 8 | CD markers Enzymes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ADORA2A | Adenosine A2a receptor | Cancer-related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
AFF2 | AF4/FMR2 family, member 2 | Disease related genes Plasma proteins
| | | | | Tissue enhanced |
AL353354.2 | | Predicted secreted proteins
| | | | | Tissue enhanced |
AL359693.1 | | | | | | | Tissue enhanced |
ALOX5 | Arachidonate 5-lipoxygenase | Enzymes FDA approved drug targets
| | | | | Tissue enhanced |
ANKRD18A | Ankyrin repeat domain-containing protein 18A | | | | | | Tissue enhanced |
ANKRD18B | Ankyrin repeat domain 18B | | | | | | Tissue enhanced |
AP003733.1 | Uncharacterized protein; cDNA FLJ36460 fis, clone THYMU2014801 | | | | | | Tissue enhanced |
AP5B1 | Adaptor-related protein complex 5, beta 1 subunit | | | | | | Tissue enhanced |
APOBEC3A | Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3A | | | | | | Tissue enhanced |
APOBEC3B | Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3B | | | | | | Tissue enhanced |
ARG1 | Arginase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Tissue enhanced |
ASTL | Astacin-like metallo-endopeptidase (M12 family) | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
ATAD5 | ATPase family, AAA domain containing 5 | Predicted secreted proteins
| | | | | Tissue enhanced |
ATP8B4 | ATPase, class I, type 8B, member 4 | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
BCL2A1 | BCL2-related protein A1 | Cancer-related genes
| | | | | Tissue enhanced |
BST1 | Bone marrow stromal cell antigen 1 | CD markers Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
C11orf21 | Chromosome 11 open reading frame 21 | | | | | | Tissue enhanced |
C16orf54 | Chromosome 16 open reading frame 54 | Predicted membrane proteins
| | | | | Tissue enhanced |
C17orf53 | Chromosome 17 open reading frame 53 | | | | | | Tissue enhanced |
C19orf38 | Chromosome 19 open reading frame 38 | Predicted membrane proteins
| | | | | Tissue enhanced |
C1orf228 | Chromosome 1 open reading frame 228 | | | | | | Tissue enhanced |
C2orf48 | Chromosome 2 open reading frame 48 | | | | | | Tissue enhanced |